[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Watcharasak Chotiyaputta\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":48},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":24,"studyType":25,"phases":4,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100659464","cardiovascular-risk-assessment-and-coronary-calcium-score-in-thai-masld-patients-100659464",false,"NCT07865936","Cardiovascular Risk Assessment and Coronary Calcium Score in Thai MASLD Patients","Association of Cardiovascular Disease Risk Assessment With Coronary Artery Calcium Score in Thai Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease","MASLD-CAC","Inclusion Criteria:\n\n* Asymptomatic\n* Diagnosed MASLD by: Ultrasound showing fatty liver, or FibroScan CAP ≥ 248 dB\u002Fm\n* Available liver fibrosis assessment (FIB-4, APRI)\n* Complete clinical and laboratory data required for cardiovascular risk assessment\n\nExclusion Criteria:\n\n* History of myocardial infarction, PCI, or CABG\n* History of stroke or peripheral arterial disease\n* History of heart failure, RV dysfunction, or pulmonary hypertension\n* Chronic hepatitis B or C\n* Autoimmune hepatitis, Wilson's disease, hemochromatosis\n* Alcohol intake \\>30 g\u002Fday (men) or \\>20 g\u002Fday (women)\n* CKD stage 4-5 or ESRD\n* Advanced cancer\n* Pregnancy",true,"ALL","35 Years","75 Years",{"count":22,"type":23},251,"ESTIMATED","10 Years","OBSERVATIONAL","Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in Thailand and is strongly linked to metabolic risk factors such as obesity, diabetes, hypertension, and dyslipidemia. Cardiovascular disease is the leading cause of death among patients with MASLD. Coronary artery calcium (CAC) scoring is a widely used marker of subclinical coronary atherosclerosis. This study aims to evaluate the association between cardiovascular risk assessment tools and CAC scores in Thai patients with MASLD to improve cardiovascular risk stratification in this population.",[28,29,30],"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","Cardiovascular Disease (CVD)","Coronary Artery Calcification",[32,33,34,35],"MASLD","Metabolic Dysfunction-Associated Steatotic Liver Disease","Coronary Artery Calcium (CAC)","Liver Disease and Cardiovascular Risk","RECRUITING","2026-10-03",{"date":39,"type":40},"2026-10-08","ACTUAL",{"date":42,"type":40},"2026-06-24",{"date":44,"type":23},"2036-06-23",{"name":46,"class":47},"Watcharasak Chotiyaputta","OTHER",""]